Between-subject variability was included about the apparent total body clearance (CL) of bioavailable drug (F; CL/F), apparent volume of distribution (V/F), and Ka terms
Between-subject variability was included about the apparent total body clearance (CL) of bioavailable drug (F; CL/F), apparent volume of distribution (V/F), and Ka terms. a median half-life of 5.6 days from the vision and 0.3 days from serum, resulting in an apparent serum half-life of 5.6 days. Time to reach maximum concentration was quick (median: […]